Our previous studies showed that the Tim-3 expression on peripheral T cell subsets was correlated with disease progression in hepatitis B infection and blockade of Tim-3 signaling could restore the virus-specific CD8+ T cell response [13, 14]. Here, HAVCR2 is linked to hepatitis B virus infection.